Tech Company Financing Transactions
InnoPharma Funding Round
InnoPharma closed a $8 million funding round on 6/7/2012. Investors included Comerica Bank and NXT Capital.
Transaction Overview
Company Name
Announced On
6/7/2012
Transaction Type
Debt
Amount
$8,000,000
Round
Undisclosed
Investors
Comerica Bank (Jeffrey Chapman)
NXT Capital (Peter Fair)
Proceeds Purpose
Proceeds will provide additional working capital and will support the Company's ongoing development of niche generic and innovative specialty pharmaceutical products in injectable and ophthalmic dosage forms.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
10 Knightsbridge Road
Piscataway, NJ 08854
USA
Piscataway, NJ 08854
USA
Phone
Website
Email Address
Overview
InnoPharma, Inc. develops niche generic and specialty pharmaceutical/bio-pharmaceutical products in sterile dosage forms, and out-licenses to pharmaceutical marketing companies for commercialization.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Navneet Puri
Chief Financial Officer
John Deighan
Chief Operating Officer
Sriram Ramanathan
Chief Scientific Officer
Satish Pejaver
Browse more venture capital transactions:
Prev: 6/7/2012: Quixey venture capital transaction
Next: 6/7/2012: Surf Air venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs